ArticleScientific reports2025
An efficient machine-learning framework for predicting protein post-translational modification sites.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- BiGKbhb: a bi-directional gated recurrent unit model for predicting lysine β-hydroxybutyrylation sites.BMC genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-Translational Modifications (PTMs), particularly lysine 2-hydroxyisobutyrylation (Khib), represent critical regulatory mechanisms governing protein structure and function, with mounting evidence underscoring their important implications in cellular metabolism, transcriptional regulation, and pathological processes. Despite this significance, the experimental identification of Khib sites remains constrained by resource-intensive methodologies and the transient nature of these modifications. To overcome these limitations, we introduce HyLightKhib, a computational framework that leverages Light Gradient Boosting Machine architecture for accurate Khib site prediction. Our approach depends on a hybrid feature extraction strategy, integrating Evolutionary Scale Modeling (ESM-2) embeddings with comprehensive Composition, Transition, and Distribution (CTD) descriptors as well as curated amino acid physicochemical properties for fixed-length peptides of 43 amino acids. The proposed classifier demonstrated considerable performance over contemporary algorithms, including XGBoost and CatBoostimplementations through mutual information-based feature selection optimization. Cross-species validation on diverse organisms including, human, parasite , and rice achieved improved Area Under the Receiver Operating Characteristic Curve (AUC-ROC) scores of 0.893, 0.876, and 0.847, respectively, outperforming existing predictors, such as DeepKhib, and ResNetKhib. HyLightKhib represents an advancement in computational PTM prediction, providing enhanced predictive performance and valuable biological insights with direct implications for functional proteomics and PTM-targeted therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.